Laboratory survey of prostate-specific antigen testing in Ontario updated

Clinical Biochemistry

Volumn 37, Issue 5, 2004, Pages 418-421

  Bunting, Peter S ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CANADA; CANCER SCREENING; DATA BASE; FOLLOW UP; HEALTH SURVEY; HUMAN; LABORATORY; LABORATORY TEST; MEDICAL INFORMATION; POSTAL MAIL; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; REVIEW;

EID: 1842839967     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.01.008     Document Type: Article

References (12)

1. Canadian Cancer Statistics. National Cancer Institute of Canada; 2003. p 18 [Table 1].
2. Ibid. Figure 3.1, p. 37.
3. Levy I.G., Gibbons L., Collins J.P., Perkins D.G., Mao Y. Prostate cancer trends in Canada: rising incidence or increased detection? Can. Med. Assoc. J. 149:1993;617-624.
4. Labrie F., Dupont A., Suburu R.et al. Serum prostate-specific antigen as a prescreening test for prostate cancer. J. Urol. 147:1992;846-852.
5. The PSA test in the early detection of prostate cancer. Final report, February 1995. Health Services Utilization and Research Commission, Government of Saskatchewan.
6. Skarsgard D., Tonita J. Prostate cancer in Saskatchewan Canada, before and during the PSA era. Cancer Causes Control. 11:2000;79-88.
7. Screening for cancer of the prostate: an evaluation of benefits, unwanted health effects, and costs. Report prepared by Conseil d'evaluation des technologies de la sante du Quebec. August 1995.
8. Bunting P.S., Miyazaki J., Goel V. Laboratory survey of prostate-specific antigen testing in Ontario. Clin. Biochem. 31:1998;47-49.
9. Bunting P.S., Chong N., Holowaty E.J., Goel V. Prostate-specific antigen utilization in Ontario: extent of testing in patients with and without cancer. Clin. Biochem. 31:1998;501-511.
10. Bunting P.S., Williams J.I., Iscoe N., Goel V. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. CMAJ. 160:1999;70-75.
11. Richter F., Dudley A.W., Irwin R.J. Jr., Sadeghi-Nejud H. Are we ordering too many PSA tests? Prostate cancer diagnosis and PSA screening patterns for a single Veterans Affairs Medical Center. J. Cancer Educ. 16:2001;38-41.
12. Bunting PS. Has there been a change in practice of screening for prostate cancer with PSA in Ontario?; (2004, in review).